Anomalies in liver biochemistry in COVID-19 patients is commonly reported, including elevations of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), serum bilirubin levels, and liver injury (25, –, 30). The gene discussed is GPT; the disease is COVID-19.